Bakuchiol protects against adverse cardiac remodeling after myocardial infarction

Conclusions:Our data suggest that BAK treatment, as a novel therapeutic strategy, protects against adverse cardiac remodeling and maintains cardiac function after MI, likely via the ERK2 and TGF- β1 signaling pathways. [Ethiop. J. Health Dev.2021; 35(3):208-219]Key Words：Bakuchiol, myocardial infarction, cardiac fibrosis, cardiac fibroblast, ERK2, TGF-β1

Source: Ethiopian Journal of Health Development - November 25, 2021 Category: African Health Authors: Yun-Jiao Duan, Zhu-Xia Shen, Ting Huang, Hui-Hui Gu, Yu-Tian Wu, Yu-Min Sun, Jun Wang Source Type: research